Nikhil Ulhas Patil

Nikhil Ulhas Patil

Active Director Director DIN 08761412
DIN 08761412 First appointment Mar 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Nikhil Ulhas Patil

Data last updated:

Nikhil Ulhas Patil is a Director at Acmesujan Pharmachem Private Limited (since 2020). The company operates in Chemicals. Acmesujan Pharmachem Private Limited reported revenue of ₹2.02 Cr (FY 2025).

DIN 08761412
Primary Designation Director
Industry Chemicals
First Appointment 23 Mar 2020
Oldest Company Age 15 yrs
Largest company Acmesujan Pharmachem Private Limited · ₹2.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acmesujan Pharmachem Private Limited U85190MH2011PTC223953
Director23 Mar 20202011₹2.02 Cr (FY 2025)Active

Board colleagues of Nikhil Ulhas Patil

Directorship timeline

Open interactive timeline →
Acmesujan Pharmachem Private Limited
Premium access

Shareholding and investment profile for Nikhil Ulhas Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikhil Ulhas Patil

Nikhil Ulhas Patil currently holds 1 directorship: Acmesujan Pharmachem Private Limited (Director, since 23 Mar 2020, revenue ₹2.02 Cr (FY 2025)).

Nikhil Ulhas Patil was first appointed on 23 Mar 2020 as Director at Acmesujan Pharmachem Private Limited.

The current boards of Nikhil Ulhas Patil's companies include Shilpa Ulhas Patil (Acmesujan Pharmachem Private Limited), Ulhas Namdeo Patil (Acmesujan Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available